Comments Off on U.S. advisory panel makes no decision on pause to J&J's COVID-19 vaccine Health News

U.S. advisory panel makes no decision on pause to J&J's COVID-19 vaccine

FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) – A U.S. health advisory panel on Wednesday did not make a decision related to the pause in the use of Johnson & Johnson’s COVID-19 vaccine, and aimed to reconvene possibly in a week or 10 days.

Source: Read Full Article

Related posts:
  1. U.S. storms delay COVID-19 vaccines in all 50 states: White House
  2. COVID infections falling worldwide but WHO warns against apathy
  3. Teachers may play role in in-school COVID-19 transmission: U.S. CDC
  4. White House says over 28 million COVID-19 vaccine doses will be available this week
  5. U.S. CDC to weigh rare clot risk with J&J's COVID-19 vaccine as use paused